Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Deerland Enzymes

Deerland Enzymes
1990 FOUNDED
M&A STATUS
Debt LATEST DEAL TYPE
3 FINANCING ROUNDS
2 INVESTMENTS
Description

Developer, formulator and manufacturer of enzyme and probiotic-based dietary supplements. The company is engaged in developing customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and proprietary formations. It also provides regulatory support and performs specialty contract manufacturing services including bulk blends, liquids, hard shell capsules and tablets as well as bottling and labeling.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 3800 Cobb International Boulevard
  • Kennesaw, GA 30152
  • United States

+1 (800) 000-0000

Deerland Enzymes Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Deerland Enzymes‘s full profile, request access.

Request full access to PitchBook

Deerland Enzymes Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arizona Nutritional Supplements Private Equity-Backed Chandler, AZ 000000000
00000 000000 Formerly VC-backed Solana Beach, CA 0 0000 00000000000 0000
00000000 Venture Capital-Backed San Francisco, CA 0000 00000000000 0000
To view this company’s complete list of competitors, request access »

Deerland Enzymes Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 31-Oct-2019 0000000000 00.000 Pharmaceuticals 00000 000000
National Enzyme Company 19-Jul-2018 Buyout/LBO BPO/Outsource Services
To view this company’s complete investment and acquisition history, request access »

Deerland Enzymes Subsidiaries (1)

Company Name Industry Location Founded
0000000 Pharmaceuticals Hundested, Denmark 0000
To view this company’s complete subsidiary history, request access »

Deerland Enzymes Executive Team (4)

Name Title Board
Seat
Contact
Info
Scott Ravech Chief Executive Officer
Hilton Dawson Chief Technology Officer
Richard DeSenna Founder
Pierre Fréchette Chairman

Deerland Enzymes Board Members (1)

Name Representing Role Since Contact
Info
000000 00é000000 Self Chairman 000 0000